In vivo treatments with a monoclonal antibody against GM-CSF in a model of chronic colitis induced by T cell transfer into Rag−/− mice, reduced EPoCs in bone marrow and dampened eosinophil chemotaxis to the inflamed colon [115]. This evidence concerns the gene CSF2 and Chronic colitis.